Dirk P Dittmer

Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR.

Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.

Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.

Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.

Novel Kaposi's sarcoma-associated herpesvirus homolog in baboons.

Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

SYBR green-based real-time quantitative PCR assay for detection of West Nile Virus circumvents false-negative results due to strain variability.

Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses.

Methylene blue photoinactivation of RNA viruses.

The tumor microenvironment controls primary effusion lymphoma growth in vivo.

De novo generation of CD4 T cells against viruses present in the host during immune reconstitution.

Real-time quantitative PCR analysis of viral transcription.

Enhanced cytotoxicity without internuclear spread of adenovirus upon cell fusion by measles virus glycoproteins.

Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma.

Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.

Whole-genome transcription profiling of rhesus monkey rhadinovirus.

Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo.

Role of Notch signal transduction in Kaposi's sarcoma-associated herpesvirus gene expression.

Faster quantitative real-time PCR protocols may lose sensitivity and show increased variability.

The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.

A naturally occurring fatal case of Herpesvirus papio 2 pneumonia in an infant baboon (Papio hamadryas anubis).

Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.

Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

Baboon model for West Nile virus infection and vaccine evaluation.

Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.

Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.

In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.

KSHV-associated disease in the AIDS patient.

Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus.

Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.

AIDS related malignancies in Brazil.

Liposomal daunorubicin as treatment for Kaposi's sarcoma.

Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma.

More on HIV-associated Kaposi's sarcoma.

EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma.

Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.

Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.

Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.

Toll-like receptor signaling controls reactivation of KSHV from latency.

Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus.

General and target-specific RNA binding properties of Epstein-Barr virus SM posttranscriptional regulatory protein.

Maribavir inhibits epstein-barr virus transcription in addition to viral DNA replication.

Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid.

Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas.

Genome-wide real-time PCR for West Nile virus reduces the false-negative rate and facilitates new strain discovery.

Efficiency clustering for low-density microarrays and its application to QPCR.

The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo.

An appraisal of non-AIDS-defining cancers: comment on "Spectrum of cancer risk late after AIDS onset in the United States".

The flu vaccine in cancer patients: insights from other immune-suppressed populations.

Interferon-γ production by neutrophils during bacterial pneumonia in mice.

Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.

Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Nuclear factor kappa B (NFkB) pathway associated biomarkers in AIDS defining malignancies.

Phosphatase and tensin homolog on chromosome 10 is phosphorylated in primary effusion lymphoma and Kaposi's sarcoma.

Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.

Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study.

Cytokine homologs of human gammaherpesviruses.

Rapalogs in viral cancers.

Latent KSHV infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokine expression.